Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity
- Xiuning Le
- Jacqulyne P. Robichaux
- Monique Nilsson
- R. S. K. Vijayan
- Ashwin Ravichandran
- Jia Wu
- Yasir Y. Elamin
- Lingzhi Hong
- Jun Pei
- Jun He
- Sonia Patel
- Hibiki Udagawa
- Sriramvignesh Mani
- Chang Woon Jang
- Jeffrey M. Clarke
- Nishan Tchekmedyian
- Jonathan W. Goldman
- Mark Socinski
- Gajanan Bhat
- Sharon Leu
- Veronica Bunn
- Zhenqiang Su
- Sylvie Vincent
- John W. Lawson
- Jason B. Cross
- John V. Heymach
2025-09-24